gvs 111 has been researched along with malondialdehyde in 2 studies
| Studies (gvs 111) | Trials (gvs 111) | Recent Studies (post-2010) (gvs 111) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
|---|---|---|---|---|---|
| 91 | 2 | 31 | 27,849 | 1,405 | 13,922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iamidanov, RS; Ostrovskaia, RU; Salimgareeva, MKh; Tsaplina, AP; Vakhitova, IuV | 1 |
| Anisina, EA; Durnev, AD; Gudasheva, TA; Ostrovskaya, RU; Yagubova, SS; Zhanataev, AK | 1 |
2 other study(ies) available for gvs 111 and malondialdehyde
| Article | Year |
|---|---|
[Effect of the novel nootropic and neuroprotective dipeptide noopept on the streptozotocin-induced model of sporadic Alzheimer disease in rats].
Topics: Alzheimer Disease; Animals; Avoidance Learning; Brain; Dipeptides; Male; Malondialdehyde; Memory; Nerve Growth Factors; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Rats; Streptozocin | 2010 |
Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptides; DNA Damage; Hyperglycemia; Insulin-Secreting Cells; Kidney; Liver; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Prediabetic State; Streptozocin | 2019 |